Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 5;5(6):ofy107.
doi: 10.1093/ofid/ofy107. eCollection 2018 Jun.

Clinical and Genomic Characterization of Recurrent Enterococcal Bloodstream Infection in Patients With Acute Leukemia

Affiliations

Clinical and Genomic Characterization of Recurrent Enterococcal Bloodstream Infection in Patients With Acute Leukemia

Julia A Messina et al. Open Forum Infect Dis. .

Abstract

Background: Rates and risk factors for recurrent enterococcal bloodstream infection (R-EBSI) and whether the same genetic lineage causes index EBSI and R-EBSI are unknown in patients with acute leukemia (AL) receiving chemotherapy.

Methods: Ninety-two AL patients with EBSI from 2010 to 2015 were included. Enterococcal bloodstream infection was defined by 31 positive blood cultures for Enterococcus faecium or Enterococcus faecalis and fever, hypotension, or chills. Clearance was defined by 31 negative cultures 324 hours after last positive culture and defervescence. Recurrent enterococcal bloodstream infection was defined by a positive blood culture for Enterococcus 324 hours after clearance. Categorical variables were reported as proportions and compared by the χ2 test. Continuous variables were summarized by median and interquartile range (IQR) and compared by the Wilcoxon-Mann-Whitney Test. P values <.05 were considered significant. Whole-genome sequencing was performed on available paired BSI isolates from 7 patients.

Results: Twenty-four patients (26%) had 31 episodes of R-EBSI. Median time to R-EBSI (IQR) was 26 (13-50) days. Patients with R-EBSI had significantly longer durations of fever and metronidazole exposure during their index EBSI. Thirty-nine percent of E. faecium R-EBSI isolates became daptomycin-nonsusceptible Enterococcus (DNSE) following daptomycin therapy for index EBSI. Whole-genome sequencing analysis confirmed high probability of genetic relatedness of index EBSI and R-EBSI isolates for 4/7 patients.

Conclusions: Recurrent enterococcal bloodstream infection and DNSE are common in patients with AL and tend to occur within the first 30 days of index EBSI. Duration of fever and metronidazole exposure may be useful in determining risk for R-EBSI. Whole-genome sequencing analysis demonstrates that the same strain causes both EBSI and R-EBSI in some patients.

Keywords: Enterococcus; acute leukemia; daptomycin-nonsusceptible Enterococcus; recurrent bloodstream infection; whole-genome sequencing.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Phylogenetic analysis of paired Enterococcus isolates from 7 patients with recurrent enterococcal bloodstream infection in relationship to previously characterized isolates. Patient number 1 represents the enterococcal bloodstream isolate from the index enterococcal bloodstream infection, and patient number 2 represents the enterococcal bloodstream isolate from the recurrent infection. Paired isolates from each patient are color-coded, with the 2 isolates from the same patient being of the same color. Reference strain citations are in Supplementary Table 1.

Similar articles

Cited by

References

    1. Ford CD, Lopansri BK, Haydoura S, et al. . Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia. Infect Control Hosp Epidemiol 2015; 36:47–53. - PubMed
    1. Ornstein MC, Mukherjee S, Keng M, et al. . Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy. Leuk Lymphoma 2015; 56:2536–42. - PubMed
    1. DiPippo AJ, Tverdek FP, Tarrand JJ, et al. . Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure. J Infect 2017; 74:243–7. - PMC - PubMed
    1. Cheah AL, Peel T, Howden BP, et al. . Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia. BMC Infect Dis 2014; 14:353. - PMC - PubMed
    1. Gudiol C, Ayats J, Camoez M, et al. . Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes. PLoS One 2013; 8:e74734. - PMC - PubMed